Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Perspectives on postgenome medicine: Gene therapy for diabetes mellitus].

Nihon rinsho. Japanese journal of clinical medicine - 1 Jan 2001

Yasuda K

Abstract excerpt

Several topics in diabetes research and practice in the coming 'post-genomic era' are described. 1) Insulin-producing pancreatic beta cells are a plausible target of gene therapy for type 1 diabetes mellitus. Functional genomics will reveal the mechanism of beta cell growth and regeneration. Attempts are being made to differentiate non-beta cells(including ES cells) into insulin-producing cells in vitro or in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calpain
Share to Cell Differentiation
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Genomics

Share to Human Genome Project

Share to Islets of Langerhans

Share to Regeneration

Source

Identifiers

PMID: 11197848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Perspectives on postgenome medicine: Gene therapy for diabetes mellitus].PMID 11197848Read ↗

[Molecular and therapeutic progress in diabetes: future perspectives].Semantic proximity Read ↗

[Type 2 diabetes and genetic variations of calpain 10 gene].Semantic proximity Read ↗

[Calpain 10 as a susceptibility gene of type 2 diabetes].Semantic proximity Read ↗

Calpain 10 and type 2 diabetes: are we getting closer to an explanation?Semantic proximity Read ↗

Genes of type 2 diabetes in beta cells.Semantic proximity Read ↗

[Personalized medicine and type-2 diabetes: pharmakogenetic aspects of drug therapy].Semantic proximity Read ↗

From stem cells to beta cells: new strategies in cell therapy of diabetes mellitusSemantic proximity Read ↗

Type 2 diabetes candidate gene CAPN10: first, but not last.Semantic proximity Read ↗

Calpain-10: from genome search to function.Semantic proximity Read ↗

Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes.Semantic proximity Read ↗

Diabetes Gene Therapy: Potential and ChallengesSemantic proximity Read ↗

[Glucokinase and non-insulin-dependent diabetes: from gene to disease].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.